自身免疫性肝炎
医学
免疫抑制
自身免疫
肝移植
免疫学
肝细胞癌
疾病
背景(考古学)
自身免疫性疾病
肝炎
肝病
移植
抗体
病理
胃肠病学
内科学
生物
古生物学
作者
Michael A. Heneghan,Andrew D. Yeoman,Sumita Verma,Alastair D. Smith,Maria Serena Longhi
出处
期刊:The Lancet
[Elsevier BV]
日期:2013-06-14
卷期号:382 (9902): 1433-1444
被引量:256
标识
DOI:10.1016/s0140-6736(12)62163-1
摘要
Autoimmune hepatitis is a disease of the hepatic parenchyma that can present in acute or chronic forms. In common with many autoimmune diseases, autoimmune hepatitis is associated with non-organ-specific antibodies in the context of hepatic autoimmunity. This dichotomy has made definition of a unifying hypothesis in the pathophysiology of the disease difficult, although data from the past 8 years have drawn attention to the role of regulatory T cells. Several triggers have been identified, and the disease arises in genetically susceptible individuals. Clinical and biochemical remission is achievable in up to 85% of cases. For the remaining patients, alternative immunosuppression strategies are an option. Liver transplantation provides an excellent outcome for patients with acute liver failure or complications of end-stage liver disease, including hepatocellular carcinoma. Variant or overlapping syndromes are worthy of consideration when unexpected disease features arise.
科研通智能强力驱动
Strongly Powered by AbleSci AI